Institutional Intelligence
Market intelligence.
Briefings, research notes and board materials on the biomanufacturing market.
Featured Briefing2026-06-18
Adjuvant Bio and a national health authority announce a strategic supply alliance for biosimilar insulin
A multi-year framework brings locally manufactured insulin glargine onto the essential-medicines list, with capacity reserved for public tender.
Read the full briefingIntelligence Feed
Strategic updates.
2026-06-18
Partnership
National supply agreement signed for insulin biosimilars
2026-05-02
Research
ADJ-415 meets primary endpoint in phase III equivalence study
2026-03-21
Facilities
Second fill-finish line commissioned at the Calder Vale campus
2026-02-10
Regulatory
Accelerated pathway filing accepted for ADJ-330
2026-01-15
Market
Regional biosimilar demand grows 18 percent year on year
2025-12-04
Research
Novel adjuvant effects characterised in vaccine development
2025-11-19
Partnership
University research council joins the talent accelerator
2025-10-30
Regulatory
Serialization rollout completed across all packaging lines
No briefings match your filter.
Subscribe to intelligence briefings.
Monthly notes on the market, the pipeline and the platform.